Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors.
about
The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline.Care models in the management of haemophilia: a systematic reviewFunctional outcomes following ankle arthrodesis in males with haemophilia: analyses using the CDC's Universal Data Collection surveillance project.Estimation of transient increases in bleeding risk associated with physical activity in children with haemophilia.The national haemophilia program standards, evaluation and oversight systems in the United States of AmericaHaemophilia utilization group study - Part Va (HUGS Va): design, methods and baseline data.Physical and psychosocial challenges in adult hemophilia patients with inhibitors.Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database.Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC databaseOutcome measures monitoring physical function in children with haemophilia: a systematic review.Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial.Body mass index and elbow range of motion in a healthy pediatric population: a possible mechanism of overweight in children.Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Association of overweight and obesity with the use of self and home-based infusion therapy among haemophilic men.Females with FVIII and FIX deficiency have reduced joint range of motionAn inventory of healthy weight practices in federally funded haemophilia treatment centres in the United StatesComprehensive care for haemophilia around the world.Similarity in joint function limitation in Type 3 von Willebrand's disease and moderate haemophilia AMeeting the emerging public health needs of persons with blood disorders.Delays in maturation among adolescents with hemophilia and a history of inhibitors.Vascular remodeling underlies rebleeding in hemophilic arthropathyAssociations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: results in adults with hemophilia in the HERO study.ESOS: a European study on the orthopaedic status of patients with haemophilia and inhibitors.Haemophilia and ageing.The natural evolution of haemophilia care: developing and sustaining comprehensive care globally.Economic burden of high-responding inhibitors in patients with hemophilia A in Taiwan.Prophylaxis in haemophilia patients with inhibitors.Modern management of haemophilic arthropathy.Can early subclinical gait changes in children with haemophilia be identified using the GAITRite walkway.New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors.Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.Von Willebrand disease in the United States: a perspective from Wisconsin.Advances and challenges in hemophilic arthropathy.Key issues in inhibitor management in patients with haemophilia.The role of disease severity in influencing body mass index in people with haemophilia: a single-institutional cross-sectional study.Septic arthritis in males with haemophilia.Repeated autologous intraarticular blood injections as an animal model for joint pain in haemophilic arthropathy.Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia.Exploring the biological basis of haemophilic joint disease: experimental studies.Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management.
P2860
Q30249256-D60D7486-A285-4D55-99B2-BD0E1F808998Q30249304-03F5EC73-4071-46B7-AF35-47B4BC6B0848Q30777781-1D2122E2-D60C-4476-A127-407E24E931E8Q33346945-0DB48590-93CF-4FF2-8813-1D5B10080A6EQ33708891-9F2D109F-49D9-497C-A2CA-819F1D0D8897Q33937275-FF9FED0F-6C6D-48D2-8C3B-6835C8108B71Q33968730-54CCD6A4-ECF9-44A5-876D-B39B03ACB48BQ34129239-9C219648-7F4D-4D9D-8EE5-A86C908937FEQ34517864-AFAA209A-C852-4A9B-BEFD-759A9F432150Q35046841-A50AA44B-CC21-45FA-8E3E-AC77726A2FB0Q35311771-0E890F6A-E27D-4294-98C1-CEF51535F599Q35654641-E18F654A-5626-4DB5-952A-6E6F9342892AQ35690807-6DC0C0B7-DC34-48F0-AADE-6ECBE0F53002Q35741813-85C4441D-1A5A-491E-9A63-9234E8919A68Q35771219-511959A1-3D85-4EF3-99A7-3422A576EB0CQ35794171-1C49DD5C-1F5D-45F1-B48A-3C31055B6DEDQ35915629-7475A15D-5E2D-4B8F-A64F-6407BECB618EQ35985208-EFA213D6-DE25-4409-A0C5-8F4676BD859FQ36057008-DC45D416-1BBE-4FA6-A14C-9AB7CA5FDB05Q36141665-0757EBA0-CC83-404D-BD1A-08AEBF598507Q36199877-BC58A13F-96A4-4B5C-A851-1FB54C5A50AFQ36244249-73B45BAC-D922-482C-8592-2D8706C3F393Q36283850-E9907BD9-40CF-46B8-85D3-898AF6E99F2CQ36473020-F7FAD70D-818C-400C-8B27-E8C6E754C6B8Q36473025-E23E0FFF-1949-4DE0-A64E-FCE060661803Q36620369-733AEC3E-D79C-44E7-A17A-B9AEF566E9E4Q36661844-86009516-2D49-4C7F-8653-47DDCC1CAF7AQ36753030-D31A762C-C852-4F9C-9E81-F7275F2DDDE4Q36945950-FE526671-D6E1-4AE3-A366-7115E24344E5Q37169669-8C541991-648D-4B11-8A26-CBD761A07FA1Q37185097-9674843E-AFB4-4D1D-979B-A2E1444F6739Q37253917-4EE3465A-A903-40E8-9CDC-62EEA2904F4EQ37279529-D9990447-F623-4800-AF7D-FD27D9807EA2Q37602415-76875D59-B91E-4128-84BF-AC29BD79720BQ37621263-A313489B-2D91-4B87-84F8-7D525FF12B3AQ37634189-E87438A9-2444-4F8A-8857-05DD5E5D61D1Q37690749-0A07F9DC-D616-4869-9CA4-205505D27C11Q37845930-58C20967-91F6-4982-888B-2AE62301241EQ37951686-CBC35FA3-D6D0-4EE4-9F45-788DCD7C3475Q37952373-9B144F80-6985-4A96-8DC5-577E32ADB410
P2860
Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Joint range-of-motion limitati ...... : prevalence and risk factors.
@en
Joint range-of-motion limitati ...... : prevalence and risk factors.
@nl
type
label
Joint range-of-motion limitati ...... : prevalence and risk factors.
@en
Joint range-of-motion limitati ...... : prevalence and risk factors.
@nl
prefLabel
Joint range-of-motion limitati ...... : prevalence and risk factors.
@en
Joint range-of-motion limitati ...... : prevalence and risk factors.
@nl
P2093
P1433
P1476
Joint range-of-motion limitati ...... : prevalence and risk factors.
@en
P2093
Angela Forsyth
Ann Forsberg
Bruce Evatt
Christy Cianfrini
Gilbert C White
Heather Huszti
J Michael Soucie
Julie Hambleton
Keith Hoots
Margaret Wagner
P304
P356
10.1182/BLOOD-2003-05-1457
P407
P577
2003-11-13T00:00:00Z